Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Simplifying QT prolongation for busy clinicians.

Grindrod KA, Nagge J.

Can Fam Physician. 2019 Apr;65(4):268-270. No abstract available.

2.

Using a course pilot in the development of an online problem-based learning (PBL) therapeutics course in a post-professional PharmD program.

Nagge JJ, Killeen R, Jennings B.

Curr Pharm Teach Learn. 2018 Feb;10(2):231-234. doi: 10.1016/j.cptl.2017.10.005. Epub 2017 Oct 18.

PMID:
29706281
3.

Evaluation of a Unique Interprofessional Education Program Involving Medical and Pharmacy Students.

Nagge JJ, Lee-Poy MF, Richard CL.

Am J Pharm Educ. 2017 Dec;81(10):6140. doi: 10.5688/ajpe6140.

4.

QT Prolongation.

Grindrod K, Nagge J, Poon A.

Can Pharm J (Ott). 2016 May;149(3):138. doi: 10.1177/1715163516642209. Epub 2016 Apr 26. No abstract available. Erratum in: Can Pharm J (Ott). 2017 May 19;150(4):226. Nagge J [added], Poon A [added].

5.

Different perspective on ASA use.

Nagge J, Bauer J.

Can Fam Physician. 2016 Jan;62(1):30-1. No abstract available.

6.

Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.

Sridhar VS, Leung P, Seymour N, Nagge J.

Can Fam Physician. 2014 Nov;60(11):e535-40.

7.

Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study.

Dhalla IA, Gomes T, Yao Z, Nagge J, Persaud N, Hellings C, Mamdani MM, Juurlink DN.

Ann Intern Med. 2013 Mar 19;158(6):447-55. doi: 10.7326/0003-4819-158-6-201303190-00004.

PMID:
23552325
8.

Pharmacist medication assessments in a surgical preadmission clinic.

Kwan Y, Fernandes OA, Nagge JJ, Wong GG, Huh JH, Hurn DA, Pond GR, Bajcar JM.

Arch Intern Med. 2007 May 28;167(10):1034-40.

PMID:
17533206
9.

Pseudoephedrine-induced toxic epidermal necrolysis.

Nagge JJ, Knowles SR, Juurlink DN, Shear NH.

Arch Dermatol. 2005 Jul;141(7):907-8. No abstract available.

PMID:
16027315
10.

Evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairment.

Nagge J, Fernandes O, Huh J.

Am Heart J. 2005 Mar;149(3):e21; author reply e23-4. No abstract available.

PMID:
15864222
11.

Acute profound thrombocytopenia associated with eptifibatide therapy.

Nagge J, Jackevicius C, Dzavik V, Ross JR, Seidelin P.

Pharmacotherapy. 2003 Mar;23(3):374-9.

PMID:
12627937
12.

Is impaired renal function a contraindication to the use of low-molecular-weight heparin?

Nagge J, Crowther M, Hirsh J.

Arch Intern Med. 2002 Dec 9-23;162(22):2605-9. Review.

PMID:
12456233
13.

Scientific developments in psychology with implications for social change.

NAGGE JW.

Trans Kans Acad Sci. 1948 Dec;51(4):473-81. No abstract available.

PMID:
18122720

Supplemental Content

Support Center